Market Tracker

03/05 6:02pm ET

SPDR® S&P Biotech ETF (XBI)

During the Trading Day
227.57 +5.51 / +2.48%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
230.07 +2.50 / +1.10%
Volume: 370.00

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+11.23% 3 years+42.24%
3 months+21.69% 5 years+30.55%
1 year+35.23% Since inception+18.12%
Data through 03/04/2015

Quote Details

Previous close$222.06
Open day’s range225.00 – 229.18
Net asset value (NAV)217.89 (03/03/2015)
Daily volume1,037,293
Average volume (3 months)707,928
Data as of 3:59pm ET, 03/05/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+30.55%+22.29%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.221.51
Net assets$2.1B$1.7B
Average market cap$2.1B$35.3B
Average P/E--26.2
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
EXEL Exelixis Inc2.18%
FMI Foundation Medicine Inc2.11%
HALO Halozyme Therapeutics Inc1.96%
NBIX Neurocrine Biosciences Inc1.85%
OPK OPKO Health Inc1.85%
PCYC Pharmacyclics Inc1.69%
ICPT Intercept Pharmaceuticals Inc1.67%
NVAX Novavax Inc1.65%
XON Intrexon Corp1.58%